Zymeworks (ZYME) Intangibles (2021 - 2026)
Zymeworks (ZYME) reported Intangibles of $1.2 million for Q1 2026, down 65.08% on a YoY basis from $3.4 million in Q1 2025, and down 13.04% sequentially from $1.3 million in Q4 2025.
Zymeworks (ZYME) Intangibles (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Intangibles data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Intangibles fell 65.08% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 65.08% YoY), and the FY2025 full-year result was $1.3 million, down 70.5% from the prior year.
- Intangibles slipped to $1.2 million in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $17.6 million in Q4 2022 to a low of $341000.0 in Q2 2024.
- A 5-year average of $6.4 million and a median of $6.4 million in 2024 frame the typical range for Intangibles.
- Across the five-year window, Intangibles tumbled 95.39% in 2024 and surged 499.71% in 2025, its largest moves.
- Tracing ZYME's Intangibles over 5 years: stood at $17.6 million in 2022, then slumped by 56.57% to $7.7 million in 2023, then slumped by 40.23% to $4.6 million in 2024, then sank by 70.5% to $1.3 million in 2025, then decreased by 13.04% to $1.2 million in 2026.
- Business Quant data shows ZYME's Intangibles at $1.2 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 3.36 Mn |
| Dec 31, 2024 | 4.58 Mn |
| Sep 30, 2024 | 6.41 Mn |
| Jun 30, 2024 | 341,000.00 |
| Mar 31, 2024 | 7.42 Mn |
| Dec 31, 2023 | 7.66 Mn |
| Sep 30, 2023 | 8.00 Mn |
| Jun 30, 2023 | 7.40 Mn |
| Mar 31, 2023 | 17.63 Mn |
| Dec 31, 2022 | 17.63 Mn |
| Sep 30, 2022 | 9.02 Mn |
| Dec 31, 2021 | 17.63 Mn |